*Corresponding Author E-mail: monishakamaraj@gmail.com
Regulatory Affairs (RA) is a profession which acts as the interface between drug regulatory authorities and regulated industries such as pharmaceuticals, medical devices, agrochemicals (plant protection products and fertilizers), energy, banking, telecom etc. Regulatory affairs also have a peculiar meaning within the healthcare industries (pharmaceuticals, medical devices, biologics and functional foods). The Gulf Cooperation Council (GCC) region is treated as “emerging market” for pharmaceuticals when compared to another region. The objective of this study was to consider regulatory authorities of each states of GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Oman, Qatar, Yemen) and pharmaceutical association perspective in the locality to evaluate review process, quality and effective measures used to improve the duration and approval process to determine the assets and liability of the centralized registration procedure.
Gulf Cooperation Council Drug Registration (GCC-DR), Gulf Cooperation Council Centralize procedure (GCC-CP), registration requirements, regulatory process, Pharmaceutical
